Our work in CONNECTIONS

Similar documents
Annual report 2009: the state of the drugs problem in Europe

Drug treatment in East and SE Asia: - the need for effective approaches

Female drug users in European prisons EXCECUTIVE SUMMARY NOVEMBER 2004

Richard H. Needle, PhD, MPH Lin Zhao, PhD candidate (UCSF School of Nursing) CSIS Africa Program Roundtable June 10, 2010

Identification and optimisation of evidence-based HCV prevention in Europe for young drug users at risk

We include a series of recommended questions for the Swedish delegation at the end of our letter.

AN OVERVIEW OF PROGRAMS FOR PEOPLE WHO INJECT DRUGS

Drug demand reduction management models - an EU perspective. Jane Mounteney EMCDDA

Dave Burrows Director

Status Paper on Prisons, Drugs and Harm Reduction

Evaluating OST programmes MMT and drug treatment in the Maldives

Insight into evaluation practices in drug treatment in Member States of the European Union

Professor Jane Fountain conferences

24 Elisad annual meeting Arezzo October 2012

ACCESS Placements!!! Apply now and spent 2 weeks in the UK in 2012 alongside service providers in the drugs and criminal justice area!!!!

MEWA HIV and Key Population programming

Getting help for a drug problem A guide to treatment

Phoenix Futures Prison Treatment programmes

EN 1 EN COMMUNICATION FROM THE COMMISSION. to the European Parliament and the Council on a EU Drugs Action Plan ( ) Introduction

Training Criminal Justice Professionals in Harm Reduction Services for Vulnerable Groups

Opioid Addiction & Corrections

REVIEW OF DRUG TREATMENT AND REHABILITATION SERVICES: SUMMARY AND ACTIONS

ISSN SELECTED ISSUE

The 2002 Report Card

Resources for the Prevention and Treatment of Substance Use Disorders

FACT SHEET SERBIA (REPUBLIC OF)

Developing the Guernsey treatment system for substance misusers: Phases One and Two. Helen Baldwin Linda Prickett Adam Marr Jim McVeigh

Testimony of The New York City Department of Health and Mental Hygiene. before the

Poor access to HCV treatment is undermining Universal Access A briefing note to the UNITAID Board

How To Treat Cannabis

Adult drug treatment plan 2007/08 Part 1 Section A: Strategic summary Section B: National targets Section C: Partnership performance expectations

HIV/AIDS mortality in Europe Monitoring mortality among injecting drug users?

Part 5: Harm Reduction

UNODC World Drug Report 2016:

Overview of Chemical Addictions Treatment. Psychology 470. Background

Preventing Avoidable Deaths:

TITLE: REVIEW OF DRUG USE IN HARLOW (PART 2 OF 2) LYNN SEWARD, HEAD OF COMMUNITY WELLBEING (01279) TEAM MANAGER (01279)

Specialist Alcohol & Drug Services in Lanarkshire

Integrated drug treatment system Treatment plan 2009/10. Part 1: Strategic summary, needs assessment and key priorities

Development of the guidelines on the pharmacotherapy of addiction case study Croatia

Briefing to the Committee Elimination of All Forms of Discrimination Against Women on the Sixth periodic report of Italy

Analysis of survey data on the implementation of NICE PH18 guidance relating to needle and syringe provision in England

The prevalence of use of psychotropic drugs, buprenorphine and methadone on the streets, the polyuse of substances in Finland

The Jobcentre Plus offer for people with drug and/or alcohol dependency

Drugs and Alcohol in Primary Care Steve Brinksman Clinical Lead SMMGP

Dublin Declaration. on Partnership to fight HIV/AIDS in Europe and Central Asia

HARM REDUCTION FOR PEOPLE WHO INJECT DRUGS INFORMATION NOTE

WHO Library Cataloguing-in-Publication Data

PROJECT: EURO-AUDITS THE EUROPEAN ROAD SAFETY AUDITOR TRAINING SYLLABUS APPENDIX E SURVEY RESULTS. October 2007

Final Report on Prevention, Treatment, and Harm Reduction Services. in Prison, on Reintegration Services on Release from Prison and

Clinical Priorities for Alcohol and Drugs in Public Health

Overview of the Breaking Free research and evaluation programme. Based on the MRC framework for developing and evaluating complex interventions

Newsletter. Drug Policy Network South East Europe CONTENTS:

drug treatment in england: the road to recovery

DMRI Drug Misuse Research Initiative

US Incarceration Rates in Comparison to other countries. World's Highest Prison Population Rates

Joint Committee on Health and Children

EXECUTIVE SUMMARY. Measuring money laundering at continental level: The first steps towards a European ambition. January 2011 EUROPEAN COMMISSION

ERASMUS FOR YOUNG ENTREPRENEURS : A NEW EXCHANGE PROGRAMME

for people coming to Scotland to work

INJECTION DRUG USE AND ITS INTERVENTIONS IN AFRICA: THE FORGOTTEN CONTINENT Some Examples From Tanzania

Treatment Approaches for Drug Addiction

Non medical use of prescription medicines existing WHO advice

Glossary Monitoring and Evaluation Terms

Community Based Treatment and Care for Drug Use and Dependence

UNITED NATIONS INTERNATIONAL NARCOTICS CONTROL BOARD. FLEXIBILITY OF TREATY PROVISIONS AS REGARDS HARM REDUCTION APPROACHES (Decision 74/10)

STW Open Technology Programme. H2020 Future & Emerging Technology. and. GRANTS WEEK 2015 October 9 th

THE STORY OF DRUG TREATMENT

EPIDEMIOLOGY OF OPIATE USE

Welcome. This presentation is designed for people working in criminal justice and drug abuse treatment settings. It provides an overview of drug

EU Competition Law. Article 101 and Article 102. January Contents

Mixed methods evaluation of the Breaking Free Online (Health and Justice) treatment and recovery programme for substance misuse in prisons

Drugs and Addiction Policy in the Federal Republic of Germany

Comprehensive HIV Prevention for People Who Inject Drugs, Revised Guidance

PERSPECTIVES ON DRUGS Trends in heroin use in Europe: what do treatment demand data tell us?

Treatment Approaches for Drug Addiction

HIV/AIDS Prevention among Injecting Drug Users: Learning from Harm Reduction in Iran

Scared Straight and other juvenile awareness programmes for preventing juvenile delinquency

GARPR Online Reporting Tool

Sheffield Future Commissioning of Drug & Alcohol Community Treatment

Principles for commissioning a substance misuse treatment system

(Only available if you have applied for a Decreasing Mortgage Cover Plan or a Level Protection Plan).

THE ROLE OF PUBLIC SUPPORT IN THE COMMERCIALISATION OF INNOVATIONS

SIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item May Hepatitis

SROM (oral morphine) an add on medication for the treatment of opioid dependence: risks & benefits. Gabriele Fischer. Medical University Vienna

MARGARET HADDOCK PRESIDENT EUROPEAN UNION FOR SUPPORTED EMPLOYMENT (EUSE) DEPUTY CHIEF EXECUTIVE THE ORCHARDVILLE SOCIETY. Brussels June 2014

Electricity, Gas and Water: The European Market Report 2014

THE PRACTICES AND CONTEXT OF PHARMACOTHERAPY OF OPIOID DEPENDENCE IN CENTRAL AND EASTERN EUROPE

DAYS Drug & Alcohol Youth Support Caerphilly & Blaenau Gwent

Why invest? How drug treatment and recovery services work for individuals, communities and society

Alcohol and drugs prevention, treatment and recovery: why invest?

National Campaign Against Drug Abuse (NACADA) Authority in Kenya. Center for Substance Abuse Treatment

Where Can I FInd Out MOre? how Can I SuppOrt a hat program In Canada?

Health care in Scotland for UK passport holders living abroad

INNOBAROMETER THE INNOVATION TRENDS AT EU ENTERPRISES

Introduction to Substance Abuse Issues in Canada: Pathways, Health Implications and Interventions

PRIORITY RULES ON COMPENSATION FOR NUCLEAR DAMAGE IN NATIONAL LEGISLATION

Fluoride and Dental Health in Europe

Report ID: EDDRA_2008_ES_02. EDDRA Questionnaire. 1. Project ID Aditional Information Project ID ES_

WHO/UNODC/UNAIDS position paper Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention

Transcription:

Our work in CONNECTIONS Collating good practices on drug treatment and harm reduction in the criminal justice system in Europe experiences from the CONNECTIONS project Cinzia Brentari EMCDDA, Lisbon, 1 March 2011 The Connections project has received funding from the European Commission under the Public Health Programme 2003-2008. 2008. However, the sole responsibility for the project lies with the author and the European Commission is not responsible for any use that may be made of the information contained therein

Background: This project builds on the work and funding that has been invested ed over 12 years in networking between European prisons and civil society organisations on issues of drugs and HIV/AIDS, with financial ncial support from the EC and other donors. Objective: to contribute to the development of more effective, inclusive, accessible and equivalent HIV/AIDS (and other drug related diseases) ses) prevention and drug treatment policies and services for at-risk populations throughout the criminal justice systems of the EU Member States and candidates countries. Partners: University of Kent (beneficiary( beneficiary) with ARAS in Romania,, University of Bremen and Frankfurt in Germany, HCLU in Hungary, Probacja in Poland, Rugby House in the UK, and T3E in the UK

International guidelines and good practice within CONNECTIONS Review available research on drug treatment and harm reduction in criminal justice systems: Available in CONNECTIONS online digest Review available international guidelines and recommendations Collect examples of good practice Create state of the art recommendations for working on drugs and related infections. Available on the CONNECTIONS website To be included in the EMCDDA s EDDRA best practice portal.

Identifying good practice examples (1) Definition of good practice and scoring: Level 1 - Promising practice: the approach has sound theoretical basis and has proved its ability to engage the target group and scores 12 or less on the quality grid Level 2 - Good practice: scores between 13 28 points on the quality grid (corresponds to Promising interventions on the EDDRA definition) Level 3 - Top level practice: scores 29 or more points on the quality grid (corresponds to Top level interventions in the EDDRA definition)

Identifying good practice examples (2) The quality grid is divided into three columns: Logic Model (11 criteria clearly stated objectives on which to base the follow up - maximum score 13 points) Evaluation (7 criteria process and outcome evaluation to see whether the activities have helped to achieve the initial objectives - maximum score 18 points) Additional Information/Deliveries (5 criteria coordination with other services, instruments for evaluation and evaluation manual - maximum score 8 points) Maximum total score 37 points

Identifying good practice examples (3) Appointment of experts: Via focal point contacts and existing network of contacts Eleven experts covering twelve countries four Eastern European and eight Western European countries Staff at Kent University also collected examples from the UK Evaluation tools: Good Practice Form records detailed information about the project (i.e. who is working with which client group, what is being done, the key features of the project, and how information is collected, analysed and interpreted to assess what outcomes the intervention has achieved) Criteria for Good Practice Form (contains the quality grid against which the project is scored to arrive at the level of good practice) Glossary of Terms Guidance Note for Experts

Identifying good practice examples (4) List is not exhaustive: Focuses on new, lesser known examples Intended as exemplars to learn from Can be added to through EMCDDA s Exchange on European Drug Demand Reduction Action

General findings Top level practice is very rare in Europe: Significant lack of rigorously evaluated interventions (very few randomised trials) Good practice has spread around Europe in the last decade Good practice is more apparent in prisons and alternative treatments than at either arrest or aftercare stages

Specific findings Prison projects Psycho-social interventions Needle exchange Opiate substitution Alternatives to imprisonment From arrest Research & development

Prison projects: Psycho-social interventions Femmeren in Denmark (Hjulsøgaardfonden) A 24 bed unit in Østjylland high security prison Includes detoxification Uses motivational enhancement, Gestalt analysis and cognitive reconstruction Achieves reductions in disciplinary incidents and improvements in physical health Women s Substance Dependency Treatment Programme (RAPt) A 20 bed unit at HMP Send Abstinence based, 12 step programme Also uses motivational enhancement and cognitive behavioural therapy Currently being evaluated by University of Manchester

Prison projects: Needle exchange Women s Prison in Berlin/Lichtenberg Established 1998 All entrants given a harm reduction kit, including a dummy syringe Syringes dispensed through automatic exchange machines Syringe sharing among IDUs reduced from 71% to 11% No HIV and HBV seroconversions, but four HCV seroconversions occurred Pereiro de Aguiar Prison, Ourense, Spain NSP introduced in 1999 93% of staff consider that there has been no increase in conflict in the prison. Syringe sharing amongst IDU inmates reduced from 46%to 7% Introduction of NSP in Romanian prisons Starting in two prisons in 2007, with support from UNODC Exchange at a central office by medical staff or peer educators No increase in drug use Observed decrease in vein injuries and abscesses.

Prison projects: Opiate substitution Slovenia Methadone from 1995, Buprenorphine from 2005 and Buprenorphine/Naloxone combination from 2007 2008 OST covers 44% of all recorded drug users in Slovenian prisons. Integrated Drug Treatment System, England & Wales Combines assessment, OST (detoxification, reduction, maintenance, reinduction) and psychosocial treatment. Including pilot alcohol interventions in some locations Aims to link to services outside prison 25,076 inductions to treatment in 2008/9 Being evaluated by NatCen Realta Prison, Switzerland Heroin assisted treatment since 2001, as well as methadone and needle exchange

Research & development Research and Intervention Program for Infectious Diseases Risk Reduction among Inmates, France: Step 1. Assessing the prevalence of risk behaviours and the availability of harm reduction measures Step 2. Randomised trial of the delivery of a harm reduction package in prisons: HBV vaccination, improved condom access, disinfecting solution, needle/syringe exchange program, HR counseling, OST, etc. Quality programme for health care services in Spanish prisons: Following rapid roll-out of OST in Spanish prisons in 1990s Quantitative survey and qualitative consultation with prison and healthcare staff Leading to the development and implementation of agreed clinical guidelines

Follow up Insertion of the good practices identified into the EDDRA database ACCESS project to continue the good practices exercise over the next 2 years

Thanks to The researchers who coordinated, carried out the work: Alex Stevens and Karen Milne-Skillman at the University of Kent The national experts: Sven Todts, Belgium Barbara Janíková, Czech Republic Niels Løppenthin, Denmark Ulla Knuuti, Finland Laurent Michel, France Heino Stöver, Germany Jadwiga Bernaś-Ude, Poland Catalina Iliuta, Romania Andrej Kastelic, Slovenia María José Bravo Portela, Spain Michael Schaub, Switzerland

More information The CONNECTIONS website (research digest and final report on good practices, international guidelines and recommendations) http://connectionsproject.eu/digest-of-research The EMCDDA Exchange on Drug Demand Reduction Action http://www.emcdda.europa.eu/themes/best-practice/examples Cinzia Brentari, ACCESS project expert at cinziabrentari@hotmail.com